Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-82,117
Closed -$6.14M 20
2022
Q4
$6.14M Buy
82,117
+11,487
+16% +$818K 5.79% 5
2022
Q3
$4.56M Sell
70,630
-6,808
-9% -$472K 4.36% 7
2022
Q2
$5.37M Buy
77,438
+12,330
+19% +$915K 4.86% 7
2022
Q1
$5M Sell
65,108
-6,030
-8% -$434K 4.41% 8
2021
Q4
$5.45M Buy
+71,138
New +$5.23M 4.13% 13

Other funds holding HOLX

Pavadi Capital's HOLX Position: Q1 2023 in Review

Pavadi Capital sold out of Hologic (HOLX) in Q1 2023, closing a stake of 82,117 shares — an estimated $6.14M sold.

Pavadi Capital first reported a position in HOLX in Q4 2021 and held it in 5 quarters. The position peaked at $6.14M in Q4 2022. 708 funds tracked by Wall St. Rank hold HOLX as of Q1 2023.

  • Pavadi Capital reported no remaining Hologic position as of Q1 2023 after selling out during the quarter.
  • Pavadi Capital sold 82,117 Hologic shares in Q1 2023, an estimated $6.14M.
  • Pavadi Capital first reported a position in Hologic in Q4 2021 and held it in 5 quarters.
  • Pavadi Capital's Hologic position peaked at $6.14M in Q4 2022.
  • 708 funds tracked by Wall St. Rank held Hologic as of Q1 2023.

Based on Pavadi Capital's 13F filing for Q1 2023, filed 15 May 2023.